Cardiac aldosterone production and ventricular remodeling

Kidney International

Volumn 57, Issue 4, 2000, Pages 1346-1351

  Delcayre, Claude ^a   Silvestre, Jean Sébastien ^a   Garnier, Anne ^a   Oubenaissa, Abdeslam ^a   Cailmail, Stephane ^a   Tatara, Estelle ^a   Swynghedauw, Bernard ^a   Robert, Valérie ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Aldosterone; Fibrosis; Heart; Mineralocorticoid receptor; Myocardial infarct

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; COLLAGEN; LOSARTAN; MESSENGER RNA; SPIRONOLACTONE;

CONFERENCE PAPER; DISEASE COURSE; FIBROGENESIS; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; REACTION ANALYSIS; STEROIDOGENESIS; TISSUE LEVEL;

EID: 0034031440     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00973.x     Document Type: Conference Paper

References (36)

1. 1. ROSSI GP, SACCHETTO A, PAVAN E, PALATINI P, GRANIERO GR, CANALI C, PESSINA AC: Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 95:1471-1478, 1997
2. 2. SWEDBERG K, ENEROTH P, KJEKSHUS J, WILHELMESEN L: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality: CONSENSUS trial study group. Circulation 82:1730-1736, 1990
3. 3. ULLIAN M: The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 41:55-64, 1999
4. 4. FUNDER JW, DUVAL D, MEYER P: Cardiac glucocorticoid receptors: The binding of triated dexamethasone in rat and dog heart. Endocrinology 93:1300-1308, 1973
5. 5. LOMBÈS M, OBLIN ME, GASC JM, BAULIEU EE, FARMAN N, BONVALET JP: Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 71:503-510, 1992
6. 6. BRILLA CG, PICK R, TAN LB, JANICKI JS, WLBER KT: Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67:1355-1364, 1990
7. 7. ROBERI V, NGUYEN VT, CHEAV SL, MOUAS C, SWYNGHEDAUW B, DELCAYRE C: Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension 24:30-36, 1994
8. 8. YOUNG M, FULLERTON M, DILLEY R, FUNDER J: Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 93:2578-2583, 1994
9. 9. SILVESTRE JS, ROBERT V, HEYMES C, AUPETTI-FAISANT B, MOUAS C, MOALIC JM, SWYNGHEDAUW B, DELCAYRE C: Myocardial production of aldosterone and corticosterone in the rat: Physiological regulation. J Biol Chem 273:4883-4891, 1998
10. 10. SILVESTRE JS, HEYMES C, OUBENAISSA A, ROBERT V, AUPETIT-FAISANT B, CARAYON A, SWYNGHEDAUW B, DELCAYRE C: Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 99:2694-2701, 1999
11. 11. FARDELLA CE, MILLER WL: Molecular biology of mineralocorticoid metabolism. Ann Rev Nutr 16:443-470, 1996
12. 12. HATAKEYAMA H, MIYAMORI I, FUJITA T, TAKEDA Y, TAKEDA R, YAMAMOTO H: Vascular aldosterone: Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 269:24316-24320, 1994
13. 13. TAKEDA Y, MIYAMORI I, YONEDA T, IKI K, HATAKEYAMA H, BLAIR IA, HSIEH FY, TAKEDA R: Production of aldosterone in isolated rat blood vessels. Hypertension 25:170-173, 1995
14. 14. TAKEDA Y, MIYAMORI I, YONEDA T, IKI K, HATAKEYAMA H, BLAIR IA, HSIEH FY, TAKEDA R: Synthesis of corticosterone in the vascular wall. Endocrinology 135:2283-2286, 1996
15. 15. LOMBÈS M, ALFAIDY N, EUGENE E, LESSANA A, FARMAN N, BONVALEI JP: Prerequisite for cardiac aldosterone action: Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart. Circulation 92:175-182, 1995
16. 16. PEARCE P, FUNDER JW: High affinity aldosterone binding sites (type 1 receptors in rat heart). Clin Exp Pharmacol Physiol 14:859-866, 1987
17. 17. LOMBÈS M, KENOUCH S, SOUQUE A, FARMAN N, RAFESTIN-OBLIN ME: The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology 135:834-840, 1994
18. +-dependent 11β-hydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 28:781-787, 1996
19. 19. WALKER BR, YAU JL, BRETT LP, SECKL JR, MONDER C, WILLIAMS BC, EDWARDS CRW: 11β-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: Implications for cardiovascular responses to glucocorticoids. Endocrinology 129:3305-3310, 1991
20. 20. FEJES-TOTH G, PEARCE D, NARAY-FEJES-TOTH A: Subcellular localization of mineralocorticoid receptors in living cells: Effects of receptor agonists and antagonists. Proc Natl Acad Sci USA 95: 2973-2978, 1998
21. 21. LIM-TIO SS, FULLER PJ: Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors. Endocrinology 139:1653-1661, 1998
22. 22. HALACHMI S, MARDEN E, MARTIN G, MACKAY H, ABBONDANZA C, BROWN M: Estrogen receptor associated proteins: Possible mediators of hormone-induced transcription. Science 264:1455-1458, 1994
23. 23. KURUKOWA R, SODERSTROM M, HORLEIN A, HALACHMI S, BROWN M, ROSENFELD MG, GLASS CK: Polarity-specific activities of retinoic acid receptors determined by a nuclear co-repressor. Nature 377:451-454, 1995
24. 24. VERREY F, KRAEHENBUHL JP, ROSSIER BC: Aldosterone induces a rapid increase in the rate of Na,K-ATPase gene transcription in cultured kidney cells. Mol Endocrinol 3:1369-1376, 1989
25. 25. WEHLING M, SPES CH, WIN N, JANSON CP, SCHMIDI BM, THEISEN K, CHRIST M: Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 83:3517-3522, 1998
26. 26. FUNDER JW: Aldosterone, salt and cardiac fibrosis. Clin Exp Hypertens 19:885-899, 1997
27. 27. BRILLA C, MAISUBARA LS, WEBER KT: Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 25:563-575, 1993
28. 28. ROBERT V, SILVESTRE JS, CHARLEMAGNE D, SABRI A, TROUVE P, WASSEF M, SWYNGHEDAUW B, DELCAYRE C: Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 26:971-978, 1995
29. 29. ROBERT V, BESSE S, SABRI A, SILVESTRE JS, ASSAYAG P, NGUYEN VT, SWYNGHEDAUW B, DELCAYRE C: Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab Invest 76:729-738, 1997
30. 30. ROBERT V, HEYMES C, SILVESTRE JS, SABRI A, SWYNGHEDAUW B, DELCAYRE C: Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: Role in aldosterone-salt induced fibrosis. Hypertension 33:981-986, 1999
31. 31. DELCAYRE C, SILVESTRE JS: Aldosterone and the heart: Towards a physiological function? Cardiovasc Res 43:7-12, 1999
32. 32. DELL'ITALIA LJ, MENG QC, BALCELLS E, WEI CC, PALMER R, HAGEMAN GR, DURAND J, HANKES GH, OPARIL S: Compartmentalization of angiotensin II generation in the dog heart: Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 100:253-258, 1997
33. 33. IKEDA U, HYMAN R, SMITH TW, MEDFORD RM: Aldosterone-mediated regulation of Na,K-ATPase gene expression in adult and neonatal rat cardiocytes. J Biol Chem 266:12058-12066, 1991
34. 3 exchanger in cultured neonatal rat cardiac cells. J Mol Cell Cardiol 27:2521-2528, 1995
35. 35. ULLIAN ME, SCHELLING JR, LINAS SL: Aldo enhances angiotensin II receptor binding and inositol phosphate responses. Hypertension 20:67-73, 1992
36. 36. BARR CS, LANG CC, HANSON J, ARNOTI M, KENNEDY N, SIRUTHERS AD: Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 76:1259-1265, 1995